SLNOW - Soleno Therapeutics Inc Warrant 2014-12.11.19 on Soleno Therapeutics Series A
Previous close
0.0354
0.035 100.000%
Share volume: 0
Last Updated: Fri 08 Nov 2019 10:00:01 PM CET
Medical Specialties:
0%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
52%
Profitability
60%
Dept financing
0%
Liquidity
0%
Performance
70%
Sector
Health Technology
Industry
Medical Specialties
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLNOW | BDXA | WMGI | RTIX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -4.86% | -15.33% |
| Return on assets | 0% | 0% | -0.27% | 0.03% |
| Return on sales | 0% | 0% | -4.54% | 0.38% |
| Return on invested capital | 0% | 0% | -3.76% | 14.41% |
| Profitability | 25% | 0% | 0% | 75% |
| Total debt ratio | 0% | 0% | 69.33% | 42.14% |
| Debt ratio change over time | 0% | 0% | -24.12% | 9.26% |
| Dept financing | 0% | 0% | 25% | 40% |
| Current Ratio | 0% | 0% | 0.85% | 1.81% |
| Quick Ratio | 0% | 0% | 0.59% | 0.63% |
| Cash Position Ratio | 0% | 0% | 0.17% | 0.04% |
| Liquididy | 0% | 0% | 55% | 62% |
| Short-term ratios | SLNOW | BDXA | WMGI | RTIX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -3.7% | -73.15% |
| Return on assets | 0% | 0% | -0.38% | -0.98% |
| Return on sales | 0% | 0% | -7.76% | -4.31% |
| Return on invested capital | 0% | 0% | -3.05% | 77.12% |
| Profitability | 75% | 0% | 0% | 25% |
| Total debt ratio | 0% | 0% | 65.82% | 65.12% |
| Debt ratio change over time | 0% | 0% | -37.9% | 64.8% |
| Dept financing | 0% | 0% | 25% | 50% |
| Current Ratio | 0% | 0% | 0.85% | 1.81% |
| Quick Ratio | 0% | 0% | 0.59% | 0.63% |
| Cash Position Ratio | 0% | 0% | 0.17% | 0.04% |
| Liquididy | 0% | 0% | 60% | 56% |